Results 81 to 90 of about 65,460 (210)

Systemic Mastocytosis

, 2015
A 64-year-old man was admitted to the hematology ward due to neutropenia and thrombocytopenia. The only symptom in the month preceding his admission, was significant weight loss.
Rontogianni, Dimitra, Pagoni, Maria, Tegos, Theodoros, Harhalakis, Nicolaos, Markou, John, Andreou, George   +5 more
core   +1 more source

A Case for Anti‐IgE Vaccination

Allergy, Volume 81, Issue 6, Page 2001-2013, June 2026.
ABSTRACT Immunoglobulin E (IgE) plays a central role in allergic diseases by binding to the high‐affinity receptor FcεRI on mast cells and basophils, where allergen‐induced crosslinking triggers potent inflammatory responses. Various mechanisms by which IgE responses are generated and functionally regulated remain elusive despite many years of research.
Paul Engeroff, Zahra Gharailoo, Monique Vogel, Martin F. Bachmann   +3 more
wiley   +1 more source

Fire ant-venom anaphylaxis prevalence in the general population and patients with systemic mastocytosis

Frontiers in Allergy
BackgroundStinging Hymenoptera can induce fatal anaphylaxis, especially in patients with systemic mastocytosis. Fire ants, Solenopsis invicta and S. richteri, from South America have recently colonized three continents.
Jeremy C. McMurray, Jeremy C. McMurray, Brandon J. Schornack, Brandon J. Schornack, Karla E. Adams, Robert L. McCoy, Amanda K. Marshall, Janet A. Brunader, Irina Maric, Dean D. Metcalfe, Nathan A. Boggs, Nathan A. Boggs   +11 more
doaj   +1 more source

Mutational status in patients with systemic mastocytosis.

, 2012
ISM, indolent systemic mastocytosis; SM-AHNMD, Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease; wt, wild-type.*UPD2pterp13.1 (homozygous DNMT3A mutation).†UPD4q12qter (homozygous KIT and TET2 mutation).‡Patients ...
Valeria Visconte (143692), Paul Elson (143703), Fred H. Hsieh (143706), Matt Kalaycio (143712), Ramon V. Tiu (143732), Jaroslaw P. Maciejewski (81785), Alan E. Lichtin (143714), Hien K. Duong (143717), Yingchun Han (143704), Raghuveer Singh Mali (143710), Reuben Kapur (143722), Sara T. Olalla Saad (143727), Hideki Makishima (143698), Anjali S. Advani (143716), Mikkael A. Sekeres (143708), Anna M. Jankowska (143695), Fabiola Traina (143689), Edward Copelan (143719), Christine L. O’Keefe (143701)   +18 more
core   +1 more source

Diagnosing Systemic Mastocytosis: State of the Art

International Journal of Laboratory Hematology, Volume 48, Issue 3, Page 551-560, June 2026.
ABSTRACT With the advent of effective multikinase and selective tyrosine kinase inhibitors in systemic mastocytosis, diagnosing this rare disease has been critical to improving patient morbidity and mortality. This state‐of‐the‐art review interprets the international diagnostic criteria, including differences between the WHO 5th edition classification ...
Anton Rets, Tracy I. George
wiley   +1 more source

Enhanced PIEZO1 expression in mast cells of mastocytosis skin lesions: Relevance to Darier's sign

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Yoshiaki Kobayashi, Nobuhiro Nakano, Nguyen Quoc Vuong Tran, Yuki Nakamura, Lisa Minai, Takashi Okamoto, Daiki Nakagomi, Tatsuki R. Kataoka, Tatsuyoshi Kawamura, Atsuhito Nakao   +9 more
wiley   +1 more source

Health inequities in pediatric anaphylaxis: A policy framework and call to action for equitable care from SIAIP allergy prevention commission

Pediatric Allergy and Immunology, Volume 37, Issue 6, June 2026.
Abstract Pediatric anaphylaxis is a rapidly evolving and potentially fatal allergic reaction whose incidence is increasing worldwide, particularly among young children. Despite international guidelines identifying intramuscular epinephrine as the first‐line, life‐saving treatment, significant health inequities persist in the prevention, recognition ...
Carolina Grella, Angela Klain, Amelia Licari, Sara Manti, Francesca Mori, Francesca Galletta, Antonio Andrea Senatore, Leonardo Tomei, Michele Miraglia del Giudice, Gian Luigi Marseglia, Cristiana Indolfi, The SIAIP Primary and Secondary Prevention of Allergic Diseases Commission   +11 more
wiley   +1 more source

Treatment Approaches for Diffuse Cutaneous Mastocytosis in Children: Literature Review and Actual Clinical Experience

Вопросы современной педиатрии
Background. Mastocytosis is a very rare disease with various manifestations, based on abnormal clonal proliferation of mast cells in organs and tissues, such as: skin, bone marrow, lymph nodes, liver, spleen, and gastrointestinal tract. The diagnosis can
Timur T. Valiev, Nikolay N. Murashkin, Tatiana S. Belysheva, Zarina G. Misikova, Daria A. Pronina, Roman V. Epishev, Roman A. Ivanov   +6 more
doaj   +1 more source

Clinical potential of midostaurin in advanced systemic mastocytosis

, 2017
Marie Olivia Chandesris,1–3 Gandhi Damaj,1,4 Olivier Lortholary,1,3,5 Olivier Hermine1–3,6 On behalf of the CEREMAST study group 1French Reference Center for Mastocytosis (CEREMAST), 2Department of Hematology, Necker Children’s Hospital,
Hermine O, Lortholary O, Chandesris MO, Damaj G   +3 more
core  

SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH MINIMAL CHANGE DISEASE

, 2016
Systemic Mastocytosis (SM) has not previously been reported in association with minimal change disease (MCD). Mastocytosis is a rare myeloproliferative disease that is characterised by uncontrolled proliferation of aberrant mast cells. This can lead to a
Sophia Otto, Juliette Hamilton, Tony Elias, Tony Amin   +3 more
core   +1 more source